Regulation of interleukin-12 production in antigen-presenting cells
- PMID: 11680011
- DOI: 10.1016/s0065-2776(01)79002-5
Regulation of interleukin-12 production in antigen-presenting cells
Abstract
Interleukin-12 is a cytokine produced by antigen-presenting cells that is essential for host defense against intracellular microbial infection and control of malignancy by virtue of its ability to stimulate both innate and adaptive immune effector cells. The immune potentiating capacity of IL-12 and its mandatory requirement in host defense predispose it to rigorous regulation. The time, localization, and magnitude of IL-12 production during an immune response strongly influence the type, extent, and, ultimately, the fate of the response. Disturbance of this evolutionarily maintained "balance of power" frequently leads to immunologic disorders. This article reviews the intricate pathways that have been uncovered in which IL-12 production is modulated by numerous pathogens and immunological regulators. The understanding of IL-12 regulation in physiological settings will undoubtedly lend valuable support to the design of therapeutic applications of IL-12.
Similar articles
-
Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.Curr Immunol Rev. 2005 Jun;1(2):119-137. doi: 10.2174/1573395054065115. Curr Immunol Rev. 2005. PMID: 21037949 Free PMC article.
-
Regulation of Interleukin-12 Production in Antigen-Presenting Cells.Adv Exp Med Biol. 2016;941:117-138. doi: 10.1007/978-94-024-0921-5_6. Adv Exp Med Biol. 2016. PMID: 27734411 Review.
-
Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells.Cell Signal. 2005 Jun;17(6):665-73. doi: 10.1016/j.cellsig.2004.12.010. Epub 2005 Jan 15. Cell Signal. 2005. PMID: 15722191 Review.
-
A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.Eur J Immunol. 1997 Oct;27(10):2634-42. doi: 10.1002/eji.1830271024. Eur J Immunol. 1997. PMID: 9368620
-
Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.Clin Exp Immunol. 2000 Jan;119(1):130-9. doi: 10.1046/j.1365-2249.2000.01041.x. Clin Exp Immunol. 2000. PMID: 10606974 Free PMC article.
Cited by
-
Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.Inflammation. 2017 Feb;40(1):303-310. doi: 10.1007/s10753-016-0453-9. Inflammation. 2017. PMID: 27696334 Review.
-
The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.Med Microbiol Immunol. 2004 Feb;193(1):1-17. doi: 10.1007/s00430-003-0186-x. Epub 2003 Jun 27. Med Microbiol Immunol. 2004. PMID: 12836019 Review.
-
The effect of CpG-ODN on antigen presenting cells of the foal.J Immune Based Ther Vaccines. 2007 Jan 25;5:1. doi: 10.1186/1476-8518-5-1. J Immune Based Ther Vaccines. 2007. PMID: 17254326 Free PMC article.
-
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545. Int J Mol Sci. 2022. PMID: 35562935 Free PMC article. Review.
-
Interleukin-35 in immune-related diseases: protection or destruction.Immunology. 2019 May;157(1):13-20. doi: 10.1111/imm.13044. Epub 2019 Mar 7. Immunology. 2019. PMID: 30681737 Free PMC article. Review.